Clinical Trial Update: Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes. [Phase 2]

View source ↗

Summary

A Phase 2 trial reports prolonged remission in children newly diagnosed with Type 1 diabetes treated with phenofibrate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Diabetes Mellitus in Children

Drugs mentioned

• phenofibrate (phenofibrate)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: UNKNOWN